U.S. Healthcare Services Stock News

BGC Group, Inc. recently reported strong second-quarter 2025 results, with revenue rising to US$784 million and net income increasing to US$57.55 million, while also issuing third-quarter guidance projecting total revenues between US$715 million and US$765 million, a significant increase from the prior year’s comparable period. The company’s updated outlook reflects accelerating growth momentum, emphasizing robust year-over-year revenue expansion that underscores rising demand for BGC’s...

Merus N.V. recently reported its second quarter 2025 results, showing revenue growth to US$8.83 million while net loss widened to US$158.22 million compared to the same period last year. A unique aspect is Merus’s strong cash reserves of US$710 million and absence of debt, giving it a runway of about 2.3 years despite increased cash burn. We’ll explore how Merus’s healthy balance sheet and rising losses together shape its current investment narrative. We've found 20 US stocks that are...

In early August 2025, Nomad Foods reported second-quarter results that exceeded analyst earnings expectations but came with a lowered full-year revenue outlook amid operational challenges and the impact of extreme weather in Western Europe. Despite these headwinds, the company increased its quarterly dividend by 13% and added Carey Dorman, a finance executive with experience in capital markets and operational oversight, to its Board of Directors as an independent member. We will now examine...

CVS Health reported its second-quarter 2025 financial results in late July, showing revenue growth to US$34.20 billion from US$30.67 billion a year ago, despite net income falling to US$1.02 billion from US$1.77 billion and the company lowering its full-year earnings guidance. A key development was the company’s decision not to repurchase any shares during the quarter, while completing a major buyback program, signaling a shift in capital allocation priorities in the face of mixed...

W.W. Grainger recently announced its second quarter 2025 earnings, reporting sales of US$4.55 billion and net income of US$482 million, along with an updated full-year sales guidance and a quarterly dividend of US$2.26 per share. The company also completed a buyback of 220,794 shares during the quarter, totaling 1.32 million shares repurchased under its current program and highlighting continued shareholder returns. With upwardly revised sales guidance but lowered full-year earnings targets,...

In the past week, EnerSys reported first-quarter revenue of US$893.02 million and net income of US$57.46 million, with adjusted earnings per share exceeding analyst forecasts. The company also increased its quarterly dividend for a third consecutive year, signaling management's confidence despite a year-on-year decline in net income. Let's look at how EnerSys’s stronger-than-expected quarterly results and dividend increase influence its investment narrative going forward. We've found 20 US...

Quince Therapeutics, Inc. recently announced a partnership with Option Care Health to prepare for the potential U.S. launch of its lead therapy, eDSP, leveraging Option Care Health's extensive pharmacy and infusion suite network. This collaboration positions Option Care Health to play a central role in providing complex treatments for rare conditions, supported by its broad national infrastructure and added service capabilities. We'll explore how Option Care Health's new partnership to...

Oddity Tech Ltd. recently reported strong second-quarter results for 2025, with net revenue of US$241.14 million and year-over-year growth in both sales and net income, followed by a raised full-year revenue outlook to US$799 million–US$804 million. This upward revision in guidance highlights management's confidence in ongoing business momentum driven by international expansion and new growth initiatives. We’ll examine how Oddity Tech’s increased full-year revenue guidance could influence...

DexCom reported strong second quarter 2025 earnings, raised full-year revenue guidance to US$4.60–4.63 billion, and announced CEO Kevin Sayer will retire on January 1, 2026, with President and COO Jake Leach named as his successor and appointed to the board. In addition, DexCom’s G7 system will now be reimbursed through Ontario’s drug benefit program, and the company introduced several new AI-driven enhancements for its glucose sensing platforms. We'll explore how DexCom's robust earnings...

Soleno Therapeutics reported second quarter 2025 earnings, highlighting US$32.66 million in initial revenue from its first commercial quarter following the launch of VYKAT XR, the first FDA-approved therapy for hyperphagia in Prader-Willi Syndrome. A unique aspect of this update is the rapid uptake of VYKAT XR, reflected in strong patient starts, expanding prescriber base, and substantial insurance coverage just months after its approval and market introduction. We'll examine how the...

Innospec Inc. recently reported mixed second quarter results, with sales rising to US$439.7 million and net income decreasing to US$23.5 million, and completed the repurchase of 123,878 shares for US$11.53 million under its buyback program announced in March 2025. Management highlighted ongoing efforts to improve margins in Performance Chemicals and Oilfield Services, while steady share repurchases and dividends underscore the company’s financial flexibility and commitment to shareholder...

Camtek Ltd. recently reported record second quarter 2025 results, with sales of US$123.32 million and net income of US$33.7 million, and provided third quarter revenue guidance of approximately US$125 million, which implies an annual run rate of around half a billion dollars in revenue. The company’s momentum is being fueled by strong customer adoption of its new Hawk and Eagle G5 inspection systems, highlighting increased demand from high-performance computing and advanced packaging...

Cogent Biosciences reported a net loss of US$73.53 million for the second quarter and US$145.52 million for the first half of 2025, both higher than the same periods last year. This ongoing increase in losses highlights the company's significant investment in its development pipeline despite the growing financial pressure. We'll examine how the rising net losses might shape Cogent Biosciences' investment narrative going forward. We've found 20 US stocks that are forecast to pay a dividend...

During the past quarter, The Cigna Group reported strong second quarter earnings with revenues of US$67.18 billion and basic earnings per share of US$5.76, alongside announcing the completion of a share repurchase of over 133 million shares, representing about 41% of outstanding shares since 2018. The company’s ongoing buybacks and earnings performance, combined with changes in board composition, signal its focus on shareholder value and corporate governance. We'll explore how robust...

In the past week, Safehold Inc. reported its second quarter 2025 results, announcing revenue of US$93.84 million and net income of US$27.95 million, with basic earnings per share from continuing operations of US$0.39. Management emphasized increased customer activity, new loan originations, and entry into affordable multifamily and hotel assets, indicating broader market reach and business diversification efforts. We'll now explore how Safehold's progress in affordable multifamily and hotel...

Acadia Healthcare Company recently reported its second quarter 2025 results, revealing revenue of US$869.23 million, a 9.2% increase year-over-year, but also a sharp decline in net income and profit margins alongside updated annual guidance and a CFO transition. This mix of strong top-line growth, higher expenses impacting earnings, and an executive change highlights persistent growth opportunities but introduces questions around cost control and financial leadership. We'll look at how...

On August 4, 2025, Advance Auto Parts completed a debt financing by issuing US$975 million of 7.000% Senior Notes due 2030 and US$975 million of 7.375% Senior Notes due 2033, with net proceeds of about US$1.92 billion intended partly to redeem existing debt and support future liquidity through a new asset-based loan facility. These moves come just before the company’s next earnings report and amid analyst expectations for significant declines in both earnings and revenue for the...

In July 2025, Lumen Technologies announced a significant private offering of US$2 billion in First Lien Notes, accompanied by its second quarter results which included a US$915 million net loss, a US$628 million goodwill impairment charge, and lower year-over-year revenue. This debt expansion and deepened loss signaled ongoing challenges with profitability and balance sheet strength as the company continues to refocus operations and manage legacy declines. We'll examine how these increased...

Magnite recently reported that for the second quarter ended June 30, 2025, its sales increased to US$173.33 million, and it delivered net income of US$11.14 million, a turnaround from a net loss during the same period last year. The company’s new collaborations, including partnerships with REMAX to launch a real estate commerce media network and with Acast for global podcast ad accessibility, showcase Magnite's increasing influence in emerging programmatic and digital advertising...

In the past week, Reddit, Inc. reported strong second-quarter earnings with revenue up to US$499.63 million and net income improving to US$89.3 million, overcoming last year’s losses. Despite facing an ongoing class action lawsuit linked to Google Search’s AI feature changes and reduced user traffic, Reddit’s return to profitability and positive analyst outlook have become the main focus for investors. We’ll explore how Reddit’s improved profitability, despite legal headwinds, could...

Pure Storage recently reported an 11% revenue increase and a 32% jump in earnings per share over the past year, alongside $941 million in insider holdings indicating leadership alignment with shareholders. The company has scheduled its second quarter fiscal 2026 earnings call for August 27, 2025, and will offer further insights at its Product & Technology-Focused Meeting for analysts during Pure//Accelerate NYC in late September, shaping expectations for its future direction. We'll examine...

Brookdale Senior Living recently reported its second quarter 2025 earnings, with revenue rising to US$812.94 million and occupancy improving to 80.1%, but with net losses also increasing and earnings missing analyst expectations. Despite higher losses, the company lifted its full-year guidance for both revenue per available room and adjusted EBITDA, signaling management's ongoing focus on operational improvement and confidence in the strength of recent occupancy gains. We'll assess how...

Lattice Semiconductor Corporation recently reported its second-quarter 2025 results, with revenue of US$123.97 million and net income of US$2.91 million, while providing upbeat guidance for third-quarter revenue between US$128 million and US$138 million. The company highlighted strong growth in Communications and Compute segments propelled by AI server demand, alongside record design wins and confidence in future growth as inventory levels normalize. We will examine how Lattice’s optimistic...

Warrior Met Coal recently released its second quarter 2025 results, reporting revenue of US$297.52 million and net income of US$5.61 million, as well as the first commercial sales from its Blue Creek mine ahead of schedule. The company also maintained its quarterly dividend, updated full-year production guidance, and amended its bylaws regarding stockholder meeting notices. Achieving earlier-than-expected sales from the Blue Creek mine marks a milestone for Warrior Met Coal, transitioning...